$BKHA

Black Hawk Acquisition Corp

No enriched coverage for $BKHA in the last 7 days.

No SEC Form 4 filings for $BKHA in the last 30 days.

Low

BKHA SEC Filings - Black Hawk Acquisition Corp 10-K, 10-Q, 8-K Forms

This article provides a comprehensive overview of Black Hawk Acquisition Corp (BKHA) SEC filings, including 10-K, 10-Q, and 8-K forms, available on Stock Titan. It details several key filings, such as the proposed merger with Vesicor Therapeutics, extension payments to the trust account, notifications of late filings, and insider ownership disclosures. The platform also offers AI-powered summaries and sentiment analysis for each document to aid investor understanding.

BKHA Stock Price and Chart — NASDAQ:BKHA

This article provides detailed financial information and performance analysis for Black Hawk Acquisition Corporation (BKHA) on NASDAQ. It covers key statistics like market capitalization, P/E ratio, and basic EPS, along with technical indicators and historical price movements. The company is a blank check company founded on September 28, 2023, and the article also addresses frequently asked questions about its stock performance and financials.

Black Hawk Acquisition Announces Sponsor-Backed Convertible Note Financing

Black Hawk Acquisition Corporation (BKHA) has announced a sponsor-backed convertible note financing of up to $300,000 from Black Hawk Management LLC to cover working capital needs. The note bears 10% annual interest and matures upon the initial business combination or liquidation, with the sponsor having the option to receive cash repayment or convert the note into equity at $1.00 per share in a DeSPAC transaction. This flexible financing structure supports the SPAC's deal execution while aligning the sponsor's incentives with the combined company's future performance.